0001237899-13-000011.txt : 20130107 0001237899-13-000011.hdr.sgml : 20130107 20130107100251 ACCESSION NUMBER: 0001237899-13-000011 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130104 FILED AS OF DATE: 20130107 DATE AS OF CHANGE: 20130107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDSTEIN JOSEPH L CENTRAL INDEX KEY: 0001225474 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 13514011 MAIL ADDRESS: STREET 1: DEPT OF PHARMACOLOGY K5 YUVER OF TEXAS STREET 2: 5323 HARRY HINES BLVD CITY: DALLAS STATE: TX ZIP: 75390 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2013-01-04 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001225474 GOLDSTEIN JOSEPH L 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2013-01-04 4 M 0 2260.0 33.42 A 2260.0 D Common Stock 2013-01-04 4 S 0 2260.0 181.22 D 0.0 D Common Stock 2013-01-04 4 M 0 2740.0 33.42 A 2740.0 D Common Stock 2013-01-04 4 S 0 2740.0 180.5 D 0.0 D Non-Qualified Stock Option (right to buy) 33.42 2013-01-04 4 M 0 2260.0 D 2021-01-03 Common Stock 2260.0 7740.0 D Non-Qualified Stock Option (right to buy) 33.42 2013-01-04 4 M 0 2740.0 D 2021-01-03 Common Stock 2740.0 5000.0 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 2,260 shares of Company stock on January 4, 2013 at prices ranging from $181.09 to $181.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 4, 2013 at each separate price. Represents volume-weighted average price of sales of 2,740 shares of Company stock on January 4, 2013 at prices ranging from $180.10 to $180.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 4, 2013 at each separate price. The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case. /s/**Joseph L. Goldstein 2013-01-07